Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials (Q2846433): Difference between revisions

From MaRDI portal
Created claim: Wikidata QID (P12): Q39467318, #quickstatements; #temporary_batch_1714786519576
ReferenceBot (talk | contribs)
Changed an Item
 
Property / cites work
 
Property / cites work: The evaluation of surrogate endpoints. / rank
 
Normal rank
Property / cites work
 
Property / cites work: The validation of surrogate endpoints in meta-analyses of randomized experiments / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Pseudoscore Estimator for Regression Problems With Two-Phase Sampling / rank
 
Normal rank
Property / cites work
 
Property / cites work: Augmented Designs to Assess Immune Response in Vaccine Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Principal Stratification in Causal Inference / rank
 
Normal rank
Property / cites work
 
Property / cites work: Evaluating Candidate Principal Surrogate Endpoints / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Generalization of Sampling Without Replacement From a Finite Universe / rank
 
Normal rank
Property / cites work
 
Property / cites work: Comparing Biomarkers as Principal Surrogate Endpoints / rank
 
Normal rank
Property / cites work
 
Property / cites work: Assessing Vaccine Effects in Repeated Low‐Dose Challenge Experiments / rank
 
Normal rank
Property / cites work
 
Property / cites work: Related Causal Frameworks for Surrogate Outcomes / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model / rank
 
Normal rank
Property / cites work
 
Property / cites work: Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials / rank
 
Normal rank

Latest revision as of 21:02, 6 July 2024

scientific article
Language Label Description Also known as
English
Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials
scientific article

    Statements

    Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    5 September 2013
    0 references
    0 references
    closeout placebo vaccination
    0 references
    estimated likelihood
    0 references
    immune correlate
    0 references
    principal surrogate
    0 references
    pseudo-score
    0 references
    two-phase sampling design
    0 references
    0 references
    0 references